Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention insights from the national cardiovascular data registry

Circulation

Volumn 132, Issue 13, 2015, Pages 1243-1251

  Sandhu, Amneet ^a   McCoy, Lisa A ^b   Negi, Smita I ^c   Hameed, Irfan ^d   Atri, Prashant ^e   Al'Aref, Subhi J ^f   Curtis, Jeptha ^g   McNulty, Ed ^h   Anderson, H Vernon ⁱ   Shroff, Adhir ^j   Menegus, Mark ^d   Swaminathan, Rajesh V ^f   Gurm, Hitinder ^k   Messenger, John ^a,l   Wang, Tracy ^b   Bradley, Steven M ^a,l  

^a UNIVERSITY OF COLORADO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f WEILL CORNELL MEDICAL CENTER   (United States)

^g YALE UNIVERSITY MEDICAL CENTER   (United States)

^h KAISER PERMANENTE   (United States)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^k UNIVERSITY OF MICHIGAN   (United States)

^l VA Eastern Colorado Health Care System   (United States)

more..

Author keywords

Advanced cardiac life support; Cardiogenic; High risk percutaneous coronary intervention; Intra Aortic balloon pump; Percutaneous coronary intervention; Shock

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; PRASUGREL; THROMBIN INHIBITOR;

AGED; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIALYSIS; DRUG THERAPY; DYSLIPIDEMIA; FEMALE; GEOGRAPHIC DISTRIBUTION; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PRIVATE HOSPITAL; PROBABILITY; PUBLIC HOSPITAL; RURAL AREA; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUBURBAN AREA; UNIVERSITY HOSPITAL; URBAN AREA; COMORBIDITY; HOSPITAL; INTRAAORTIC BALLOON PUMP; MEDICAL SOCIETY; MIDDLE AGED; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SHOCK, CARDIOGENIC; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; UTILIZATION; VERY ELDERLY; CONGESTIVE HEART FAILURE; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; HIGH RISK PATIENT; LEFT VENTRICULAR ASSIST DEVICE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; SECONDARY ANALYSIS; TREND STUDY;

AGED; AGED, 80 AND OVER; ASSISTED CIRCULATION; COMORBIDITY; FEMALE; HOSPITALS; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84951016281     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.014451     Document Type: Article

References (26)

1. Cheng JM, den Uil, CA, Hoeks SE, van der Ent, M, Jewbali LS, van Domburg, RT, Serruys PW. Percutaneous left ventricular assist devices vs. intra- Aortic balloon pump counterpulsation for treatment of cardiogenic shock: A meta- Analysis of controlled trials. Eur Heart J. 2009;30:2102- 2108. doi:10.1093/eurheartj/ehp292.
2. Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation. 2012;125:1809-1817. doi:10.1161/CIRCULATIONAHA.111.040220.
3. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Hans-Heinrich M, Butter C, Engstrom T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engstrom AE, Henriques JP. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device: The Europella Registry. J Am Coll Cardiol 2009; 54: 15-22.
4. Henriques JP, Remmelink M, Baan J Jr, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BA, Tijssen JG, Piek JJ, de Winter, RJ. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol. 2006;97:990-992. doi:10.1016/j.amjcard.2005.10.037.
5. Aragon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv. 2005;65:346-352. doi:10.1002/ccd.20339.
6. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;2:91-96. doi:10.1016/j.jcin.2008.11.005.
7. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra- Aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584-1588. doi:10.1016/j.jacc.2008.05.065.
8. O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra- Aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The PROTECT II study. Circulation. 2012;126:1717-1727. doi:10.1161/CIRCULATIONAHA.112.098194.
9. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra- Aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276-1283. doi:10.1093/eurheartj/ehi161.
10. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:e1-e8. doi:10.1016/j.ahj.2006.05.031.
11. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287-1296. doi:10.1056/NEJMoa1208410.
12. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): Building a national clinical data repository. J Am Coll Cardiol. 2001;37:2240-2245.
13. Weintraub WS, McKay CR, Riner RN, Ellis SG, Frommer PL, Carmichael DB, Hammermeister KE, Effros MN, Bost JE, Bodycombe DP. The American College of Cardiology National Database: progress and challenges. American College of Cardiology Database Committee. J Am Coll Cardiol. 1997;29:459-465.
14. Coder's Data Dictionary. NCDR CathPCI Registry. https://www.ncdr.com/WebNCDR/docs/public-data-collection-documents/cathpci-v4-codersdictionary-4-4.pdf?sfvrsn=2 Accessed June 12, 2014.
15. Diagnostic Catheterization and Percutaneous Coronary Intervention Registry. NCDR CathPCI Registry. https://www.ncdr.com/WebNCDR/docs/public-data-collection-documents/cathpci-v4-datacollectionform-4-4.pdf?sfvrsn=2. Accessed June 12, 2014.
16. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113:156-175. doi:10.1161/CIRCULATIONAHA.105.170815.
17. Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM. Use and effectiveness of intra- Aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2012;5:21-30. doi:10.1161/CIRCOUTCOMES.110.960385.
18. The Dartmouth Atlas of Healthcare. http://www.dartmouthatlas.org. Accessed September 3, 2014.
19. Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short- Term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;64:1407-1415. doi:10.1016/j.jacc.2014.07.958.
20. HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2012. www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed November 20, 2014.
21. Ghali WA, Ash AS, Hall RE, Moskowitz MA. Variation in hospital rates of intraaortic balloon pump use in coronary artery bypass operations. Ann Thorac Surg. 1999;67:441-445.
22. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Role of prophylactic intra- Aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006;98:608-612. doi:10.1016/j.amjcard.2006.03.036.
23. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, Spanos V, Carlino M, Montorfano M, Di Mario C, Colombo A. Elective versus provisional intraaortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003;145:700-707. doi:10.1067/mhj.2003.14.
24. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S; BCIS-1 Investigators. Elective intra- Aortic balloon counterpulsation during high-risk percutaneous coronary intervention: A randomized controlled trial. JAMA. 2010;304:867-874. doi:10.1001/jama.2010.1190.
25. Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S; BCIS-1 Investigators. Long- Term mortality data from the balloon pump- Assisted coronary intervention study (BCIS-1): A randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013;127:207-212. doi:10.1161/CIRCULATIONAHA.112.132209.
26. Moussa I, Hermann A, Messenger JC, Dehmer GJ, Weaver WD, Rumsfeld JS, Masoudi FA. The NCDR CathPCI Registry: A US national perspective on care and outcomes for percutaneous coronary intervention. Heart. 2013;99:297-303. doi:10.1136/heartjnl-2012-303379.